01 1Aurobindo Pharma Limited
01 1CLORAZEPATE DIPOTASSIUM USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-04-22
Pay. Date : 2025-03-26
DMF Number : 41337
Submission : 2025-03-17
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CLORAZEPATE DIPOTASSIUM USP, with a corresponding US DMF Number 41337.
Remarkably, this DMF maintains an Active status since its submission on March 17, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 22, 2025, and payment made on March 26, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
